This article discusses the Monaco Memo and best practices for companies when building their compliance programs.
General Publications
March 21, 2023
"Monaco Memo and Its Impact on Antitrust Compliance Programs," American Bar Association, March 21, 2023.
Related News & Insights
-
Speaking Engagement March 12, 2025Antitrust Updates – Deals, Data, and PlatformsParker Miller will present at this event hosted by the State Bar of Georgia Antitrust Law Section.
-
Advisories February 18, 2025Antitrust Advisory | Foreign Direct Investment Screening in Germany in 2024: Key Facts & FiguresOur European Antitrust Team provides insights into German foreign direct investment (FDI) control in 2024.
-
Advisories February 3, 2025Consumer Protection/FTC / Antitrust Advisory | Flurry of FTC Action in the Final Days of the Khan FTC Precedes Transition to the Ferguson FTCOur Consumer Protection/FTC and Antitrust Teams highlight a spate of activity by the Federal Trade Commission (FTC) in its final days under the leadership of Lina Khan and offers a preview of what’s to come with Andrew Ferguson at the helm.
-
Advisories January 31, 2025Antitrust / Mergers & Acquisitions Advisory | FTC Increases Hart–Scott–Rodino Act Thresholds and Filing Fees for 2025 as New Rules Scheduled to Take EffectOur Antitrust and Mergers & Acquisitions Groups analyze this year’s Hart–Scott–Rodino (HSR) Act adjustments and the future of pending HSR rules.
-
Press Release December 13, 2024Alston & Bird Advises Veritiv on Sale of Rigid-Packaging BusinessAlston & Bird advised Veritiv Operating Company, a leader in specialty packaging distribution, on the sale of Veritiv Containers, the company’s rigid-packaging business, to TricorBraun, a global packaging leader. Pending regulatory approval, the sale is expected to be completed in the first quarter of 2025.
-
Speaking Engagement November 21, 2024Time for a Checkup: Evaluating the Withdrawal of the Health Care Antitrust GuidelinesAdam Biegel will speak during this webinar hosted by Federalist Society.
-
Press Release November 15, 2024Alston & Bird Secures Litigation Win for SandozOn November 4, Alston & Bird secured over $70 million in damages for client Sandoz in litigation against biopharmaceutical firm United Therapeutics Corp. (UTC). In 2019, Sandoz filed a suit alleging UTC blocked the sale of a generic version of hypertension medication by colluding with the manufacturer of infusion pumps for injecting UTC’s brand-name hypertension drug Remodulin to muscle out Sandoz’s generic alternative. Following a three-day bench trial, U.S. District Judge Brian R. Martinotti found Sandoz lost profits of $137.2 million and entered a judgment in favor of Sandoz, awarding damages of $61.6 million, plus prejudgment interest of $8.9 million, on its breach of contract claim against UTC. The win was featured in The American Lawyer’s Litigator of the Week, Law360’s Legal Lions column, and The New Jersey Law Journal.
-
Advisories November 13, 2024Antitrust / Mergers & Acquisitions Advisory | FTC Advances Significant Changes to Premerger Notification Process: Change of Administration Adds New UncertaintyAt long last, the Federal Trade Commission has approved a final rule to expand the pre-merger filling requirements under the Hart-Scott-Rodino (HSR) Act. Our Antitrust and Mergers & Acquisitions teams weigh in.
-
Press Release November 7, 2024Alston & Bird Earns 126 Tier-1 Rankings in 2025 Best Law FirmsAlston & Bird has been honored as one of the nation’s top law firms in the 2025 edition of Best Law Firms®, ranked by Best Lawyers.
-
Advisories November 1, 2024Antitrust Advisory | EU and UK Strike Deal on Cooperation in Competition InvestigationsOur Antitrust Team discusses the intricacies of the upcoming competition cooperation agreement (CCA) between the European Union and UK that will allow better coordination of enforcement of competition laws in parallel investigations.
Media Contact